世界のバッテン病治療薬パイプライン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Batten Disease Drug Pipeline Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3890
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、バッテン病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療薬、造血幹細胞治療薬）、用途別市場規模（病院＆診療所、専門施設）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・バッテン病治療薬パイプラインの市場動向
・企業の競争状況、市場シェア
・バッテン病治療薬パイプラインの種類別市場規模と予測2016-2027（遺伝子治療薬、造血幹細胞治療薬）
・バッテン病治療薬パイプラインの用途別市場規模と予測2016-2027（病院＆診療所、専門施設）
・バッテン病治療薬パイプラインの北米市場規模2016-2027（アメリカ、カナダ）
・バッテン病治療薬パイプラインの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・バッテン病治療薬パイプラインのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・バッテン病治療薬パイプラインの中南米市場規模2016-2027（メキシコ、ブラジル）
・バッテン病治療薬パイプラインの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abeona Therapeutics Inc、Amicus Therapeutics、Blue Turtle Bio Technologies Inc、Circumvent Pharmaceuticals Inc、Collaborations Pharmaceuticals Inc、Exicure Inc、Polaryx Therapeutics Inc、RegenxBio Inc、Retrotope Inc）
・結論

Market Analysis and Insights: Global Batten Disease Drug Pipeline Market
The global Batten Disease Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Batten Disease Drug Pipeline market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Batten Disease Drug Pipeline market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Batten Disease Drug Pipeline market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Batten Disease Drug Pipeline market.

Global Batten Disease Drug Pipeline Scope and Market Size
Batten Disease Drug Pipeline market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Batten Disease Drug Pipeline market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Gene Drugs
Stem Cell Drugs

Segment by Application
Hospital and Clinics
Specialty Centers

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abeona Therapeutics Inc
Amicus Therapeutics
Blue Turtle Bio Technologies Inc
Circumvent Pharmaceuticals Inc
Collaborations Pharmaceuticals Inc
Exicure Inc
Polaryx Therapeutics Inc
RegenxBio Inc
Retrotope Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Batten Disease Drug Pipeline Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gene Drugs
1.2.3 Stem Cell Drugs
1.3 Market by Application
1.3.1 Global Batten Disease Drug Pipeline Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital and Clinics
1.3.3 Specialty Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Batten Disease Drug Pipeline Market Perspective (2016-2027)
2.2 Batten Disease Drug Pipeline Growth Trends by Regions
2.2.1 Batten Disease Drug Pipeline Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Batten Disease Drug Pipeline Historic Market Share by Regions (2016-2021)
2.2.3 Batten Disease Drug Pipeline Forecasted Market Size by Regions (2022-2027)
2.3 Batten Disease Drug Pipeline Industry Dynamic
2.3.1 Batten Disease Drug Pipeline Market Trends
2.3.2 Batten Disease Drug Pipeline Market Drivers
2.3.3 Batten Disease Drug Pipeline Market Challenges
2.3.4 Batten Disease Drug Pipeline Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Batten Disease Drug Pipeline Players by Revenue
3.1.1 Global Top Batten Disease Drug Pipeline Players by Revenue (2016-2021)
3.1.2 Global Batten Disease Drug Pipeline Revenue Market Share by Players (2016-2021)
3.2 Global Batten Disease Drug Pipeline Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Batten Disease Drug Pipeline Revenue
3.4 Global Batten Disease Drug Pipeline Market Concentration Ratio
3.4.1 Global Batten Disease Drug Pipeline Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Batten Disease Drug Pipeline Revenue in 2020
3.5 Batten Disease Drug Pipeline Key Players Head office and Area Served
3.6 Key Players Batten Disease Drug Pipeline Product Solution and Service
3.7 Date of Enter into Batten Disease Drug Pipeline Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Batten Disease Drug Pipeline Breakdown Data by Type
4.1 Global Batten Disease Drug Pipeline Historic Market Size by Type (2016-2021)
4.2 Global Batten Disease Drug Pipeline Forecasted Market Size by Type (2022-2027)

5 Batten Disease Drug Pipeline Breakdown Data by Application
5.1 Global Batten Disease Drug Pipeline Historic Market Size by Application (2016-2021)
5.2 Global Batten Disease Drug Pipeline Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Batten Disease Drug Pipeline Market Size (2016-2027)
6.2 North America Batten Disease Drug Pipeline Market Size by Type
6.2.1 North America Batten Disease Drug Pipeline Market Size by Type (2016-2021)
6.2.2 North America Batten Disease Drug Pipeline Market Size by Type (2022-2027)
6.2.3 North America Batten Disease Drug Pipeline Market Size by Type (2016-2027)
6.3 North America Batten Disease Drug Pipeline Market Size by Application
6.3.1 North America Batten Disease Drug Pipeline Market Size by Application (2016-2021)
6.3.2 North America Batten Disease Drug Pipeline Market Size by Application (2022-2027)
6.3.3 North America Batten Disease Drug Pipeline Market Size by Application (2016-2027)
6.4 North America Batten Disease Drug Pipeline Market Size by Country
6.4.1 North America Batten Disease Drug Pipeline Market Size by Country (2016-2021)
6.4.2 North America Batten Disease Drug Pipeline Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Batten Disease Drug Pipeline Market Size (2016-2027)
7.2 Europe Batten Disease Drug Pipeline Market Size by Type
7.2.1 Europe Batten Disease Drug Pipeline Market Size by Type (2016-2021)
7.2.2 Europe Batten Disease Drug Pipeline Market Size by Type (2022-2027)
7.2.3 Europe Batten Disease Drug Pipeline Market Size by Type (2016-2027)
7.3 Europe Batten Disease Drug Pipeline Market Size by Application
7.3.1 Europe Batten Disease Drug Pipeline Market Size by Application (2016-2021)
7.3.2 Europe Batten Disease Drug Pipeline Market Size by Application (2022-2027)
7.3.3 Europe Batten Disease Drug Pipeline Market Size by Application (2016-2027)
7.4 Europe Batten Disease Drug Pipeline Market Size by Country
7.4.1 Europe Batten Disease Drug Pipeline Market Size by Country (2016-2021)
7.4.2 Europe Batten Disease Drug Pipeline Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Batten Disease Drug Pipeline Market Size (2016-2027)
8.2 Asia-Pacific Batten Disease Drug Pipeline Market Size by Type
8.2.1 Asia-Pacific Batten Disease Drug Pipeline Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Batten Disease Drug Pipeline Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Batten Disease Drug Pipeline Market Size by Type (2016-2027)
8.3 Asia-Pacific Batten Disease Drug Pipeline Market Size by Application
8.3.1 Asia-Pacific Batten Disease Drug Pipeline Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Batten Disease Drug Pipeline Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Batten Disease Drug Pipeline Market Size by Application (2016-2027)
8.4 Asia-Pacific Batten Disease Drug Pipeline Market Size by Region
8.4.1 Asia-Pacific Batten Disease Drug Pipeline Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Batten Disease Drug Pipeline Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Batten Disease Drug Pipeline Market Size (2016-2027)
9.2 Latin America Batten Disease Drug Pipeline Market Size by Type
9.2.1 Latin America Batten Disease Drug Pipeline Market Size by Type (2016-2021)
9.2.2 Latin America Batten Disease Drug Pipeline Market Size by Type (2022-2027)
9.2.3 Latin America Batten Disease Drug Pipeline Market Size by Type (2016-2027)
9.3 Latin America Batten Disease Drug Pipeline Market Size by Application
9.3.1 Latin America Batten Disease Drug Pipeline Market Size by Application (2016-2021)
9.3.2 Latin America Batten Disease Drug Pipeline Market Size by Application (2022-2027)
9.3.3 Latin America Batten Disease Drug Pipeline Market Size by Application (2016-2027)
9.4 Latin America Batten Disease Drug Pipeline Market Size by Country
9.4.1 Latin America Batten Disease Drug Pipeline Market Size by Country (2016-2021)
9.4.2 Latin America Batten Disease Drug Pipeline Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Batten Disease Drug Pipeline Market Size (2016-2027)
10.2 Middle East & Africa Batten Disease Drug Pipeline Market Size by Type
10.2.1 Middle East & Africa Batten Disease Drug Pipeline Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Batten Disease Drug Pipeline Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Batten Disease Drug Pipeline Market Size by Type (2016-2027)
10.3 Middle East & Africa Batten Disease Drug Pipeline Market Size by Application
10.3.1 Middle East & Africa Batten Disease Drug Pipeline Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Batten Disease Drug Pipeline Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Batten Disease Drug Pipeline Market Size by Application (2016-2027)
10.4 Middle East & Africa Batten Disease Drug Pipeline Market Size by Country
10.4.1 Middle East & Africa Batten Disease Drug Pipeline Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Batten Disease Drug Pipeline Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abeona Therapeutics Inc
11.1.1 Abeona Therapeutics Inc Company Details
11.1.2 Abeona Therapeutics Inc Business Overview
11.1.3 Abeona Therapeutics Inc Batten Disease Drug Pipeline Introduction
11.1.4 Abeona Therapeutics Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.1.5 Abeona Therapeutics Inc Recent Development
11.2 Amicus Therapeutics
11.2.1 Amicus Therapeutics Company Details
11.2.2 Amicus Therapeutics Business Overview
11.2.3 Amicus Therapeutics Batten Disease Drug Pipeline Introduction
11.2.4 Amicus Therapeutics Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.2.5 Amicus Therapeutics Recent Development
11.3 Blue Turtle Bio Technologies Inc
11.3.1 Blue Turtle Bio Technologies Inc Company Details
11.3.2 Blue Turtle Bio Technologies Inc Business Overview
11.3.3 Blue Turtle Bio Technologies Inc Batten Disease Drug Pipeline Introduction
11.3.4 Blue Turtle Bio Technologies Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.3.5 Blue Turtle Bio Technologies Inc Recent Development
11.4 Circumvent Pharmaceuticals Inc
11.4.1 Circumvent Pharmaceuticals Inc Company Details
11.4.2 Circumvent Pharmaceuticals Inc Business Overview
11.4.3 Circumvent Pharmaceuticals Inc Batten Disease Drug Pipeline Introduction
11.4.4 Circumvent Pharmaceuticals Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.4.5 Circumvent Pharmaceuticals Inc Recent Development
11.5 Collaborations Pharmaceuticals Inc
11.5.1 Collaborations Pharmaceuticals Inc Company Details
11.5.2 Collaborations Pharmaceuticals Inc Business Overview
11.5.3 Collaborations Pharmaceuticals Inc Batten Disease Drug Pipeline Introduction
11.5.4 Collaborations Pharmaceuticals Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.5.5 Collaborations Pharmaceuticals Inc Recent Development
11.6 Exicure Inc
11.6.1 Exicure Inc Company Details
11.6.2 Exicure Inc Business Overview
11.6.3 Exicure Inc Batten Disease Drug Pipeline Introduction
11.6.4 Exicure Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.6.5 Exicure Inc Recent Development
11.7 Polaryx Therapeutics Inc
11.7.1 Polaryx Therapeutics Inc Company Details
11.7.2 Polaryx Therapeutics Inc Business Overview
11.7.3 Polaryx Therapeutics Inc Batten Disease Drug Pipeline Introduction
11.7.4 Polaryx Therapeutics Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.7.5 Polaryx Therapeutics Inc Recent Development
11.8 RegenxBio Inc
11.8.1 RegenxBio Inc Company Details
11.8.2 RegenxBio Inc Business Overview
11.8.3 RegenxBio Inc Batten Disease Drug Pipeline Introduction
11.8.4 RegenxBio Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.8.5 RegenxBio Inc Recent Development
11.9 Retrotope Inc
11.9.1 Retrotope Inc Company Details
11.9.2 Retrotope Inc Business Overview
11.9.3 Retrotope Inc Batten Disease Drug Pipeline Introduction
11.9.4 Retrotope Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021)
11.9.5 Retrotope Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Batten Disease Drug Pipeline Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gene Drugs
Table 3. Key Players of Stem Cell Drugs
Table 4. Global Batten Disease Drug Pipeline Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Batten Disease Drug Pipeline Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Batten Disease Drug Pipeline Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Batten Disease Drug Pipeline Market Share by Regions (2016-2021)
Table 8. Global Batten Disease Drug Pipeline Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Batten Disease Drug Pipeline Market Share by Regions (2022-2027)
Table 10. Batten Disease Drug Pipeline Market Trends
Table 11. Batten Disease Drug Pipeline Market Drivers
Table 12. Batten Disease Drug Pipeline Market Challenges
Table 13. Batten Disease Drug Pipeline Market Restraints
Table 14. Global Batten Disease Drug Pipeline Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Batten Disease Drug Pipeline Market Share by Players (2016-2021)
Table 16. Global Top Batten Disease Drug Pipeline Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Batten Disease Drug Pipeline as of 2020)
Table 17. Ranking of Global Top Batten Disease Drug Pipeline Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Batten Disease Drug Pipeline Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Batten Disease Drug Pipeline Product Solution and Service
Table 21. Date of Enter into Batten Disease Drug Pipeline Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Batten Disease Drug Pipeline Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Batten Disease Drug Pipeline Revenue Market Share by Type (2016-2021)
Table 25. Global Batten Disease Drug Pipeline Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Batten Disease Drug Pipeline Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Batten Disease Drug Pipeline Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Batten Disease Drug Pipeline Revenue Market Share by Application (2016-2021)
Table 29. Global Batten Disease Drug Pipeline Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Batten Disease Drug Pipeline Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Batten Disease Drug Pipeline Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Batten Disease Drug Pipeline Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Batten Disease Drug Pipeline Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Batten Disease Drug Pipeline Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Batten Disease Drug Pipeline Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Batten Disease Drug Pipeline Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Batten Disease Drug Pipeline Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Batten Disease Drug Pipeline Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Batten Disease Drug Pipeline Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Batten Disease Drug Pipeline Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Batten Disease Drug Pipeline Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Batten Disease Drug Pipeline Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Batten Disease Drug Pipeline Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Batten Disease Drug Pipeline Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Batten Disease Drug Pipeline Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Batten Disease Drug Pipeline Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Batten Disease Drug Pipeline Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Batten Disease Drug Pipeline Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Batten Disease Drug Pipeline Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Batten Disease Drug Pipeline Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Batten Disease Drug Pipeline Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Batten Disease Drug Pipeline Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Batten Disease Drug Pipeline Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Batten Disease Drug Pipeline Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Batten Disease Drug Pipeline Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Batten Disease Drug Pipeline Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Batten Disease Drug Pipeline Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Batten Disease Drug Pipeline Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Batten Disease Drug Pipeline Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Batten Disease Drug Pipeline Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abeona Therapeutics Inc Company Details
Table 62. Abeona Therapeutics Inc Business Overview
Table 63. Abeona Therapeutics Inc Batten Disease Drug Pipeline Product
Table 64. Abeona Therapeutics Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 65. Abeona Therapeutics Inc Recent Development
Table 66. Amicus Therapeutics Company Details
Table 67. Amicus Therapeutics Business Overview
Table 68. Amicus Therapeutics Batten Disease Drug Pipeline Product
Table 69. Amicus Therapeutics Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 70. Amicus Therapeutics Recent Development
Table 71. Blue Turtle Bio Technologies Inc Company Details
Table 72. Blue Turtle Bio Technologies Inc Business Overview
Table 73. Blue Turtle Bio Technologies Inc Batten Disease Drug Pipeline Product
Table 74. Blue Turtle Bio Technologies Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 75. Blue Turtle Bio Technologies Inc Recent Development
Table 76. Circumvent Pharmaceuticals Inc Company Details
Table 77. Circumvent Pharmaceuticals Inc Business Overview
Table 78. Circumvent Pharmaceuticals Inc Batten Disease Drug Pipeline Product
Table 79. Circumvent Pharmaceuticals Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 80. Circumvent Pharmaceuticals Inc Recent Development
Table 81. Collaborations Pharmaceuticals Inc Company Details
Table 82. Collaborations Pharmaceuticals Inc Business Overview
Table 83. Collaborations Pharmaceuticals Inc Batten Disease Drug Pipeline Product
Table 84. Collaborations Pharmaceuticals Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 85. Collaborations Pharmaceuticals Inc Recent Development
Table 86. Exicure Inc Company Details
Table 87. Exicure Inc Business Overview
Table 88. Exicure Inc Batten Disease Drug Pipeline Product
Table 89. Exicure Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 90. Exicure Inc Recent Development
Table 91. Polaryx Therapeutics Inc Company Details
Table 92. Polaryx Therapeutics Inc Business Overview
Table 93. Polaryx Therapeutics Inc Batten Disease Drug Pipeline Product
Table 94. Polaryx Therapeutics Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 95. Polaryx Therapeutics Inc Recent Development
Table 96. RegenxBio Inc Company Details
Table 97. RegenxBio Inc Business Overview
Table 98. RegenxBio Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 99. RegenxBio Inc Recent Development
Table 100. Retrotope Inc Company Details
Table 101. Retrotope Inc Business Overview
Table 102. Retrotope Inc Batten Disease Drug Pipeline Product
Table 103. Retrotope Inc Revenue in Batten Disease Drug Pipeline Business (2016-2021) & (US$ Million)
Table 104. Retrotope Inc Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Batten Disease Drug Pipeline Market Share by Type: 2020 VS 2027
Figure 2. Gene Drugs Features
Figure 3. Stem Cell Drugs Features
Figure 4. Global Batten Disease Drug Pipeline Market Share by Application: 2020 VS 2027
Figure 5. Hospital and Clinics Case Studies
Figure 6. Specialty Centers Case Studies
Figure 7. Batten Disease Drug Pipeline Report Years Considered
Figure 8. Global Batten Disease Drug Pipeline Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Batten Disease Drug Pipeline Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Batten Disease Drug Pipeline Market Share by Regions: 2020 VS 2027
Figure 11. Global Batten Disease Drug Pipeline Market Share by Regions (2022-2027)
Figure 12. Global Batten Disease Drug Pipeline Market Share by Players in 2020
Figure 13. Global Top Batten Disease Drug Pipeline Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Batten Disease Drug Pipeline as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Batten Disease Drug Pipeline Revenue in 2020
Figure 15. Global Batten Disease Drug Pipeline Revenue Market Share by Type (2016-2021)
Figure 16. Global Batten Disease Drug Pipeline Revenue Market Share by Type (2022-2027)
Figure 17. North America Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Batten Disease Drug Pipeline Market Share by Type (2016-2027)
Figure 19. North America Batten Disease Drug Pipeline Market Share by Application (2016-2027)
Figure 20. North America Batten Disease Drug Pipeline Market Share by Country (2016-2027)
Figure 21. United States Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Batten Disease Drug Pipeline Market Share by Type (2016-2027)
Figure 25. Europe Batten Disease Drug Pipeline Market Share by Application (2016-2027)
Figure 26. Europe Batten Disease Drug Pipeline Market Share by Country (2016-2027)
Figure 27. Germany Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Batten Disease Drug Pipeline Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Batten Disease Drug Pipeline Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Batten Disease Drug Pipeline Market Share by Region (2016-2027)
Figure 37. China Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Batten Disease Drug Pipeline Market Share by Type (2016-2027)
Figure 45. Latin America Batten Disease Drug Pipeline Market Share by Application (2016-2027)
Figure 46. Latin America Batten Disease Drug Pipeline Market Share by Country (2016-2027)
Figure 47. Mexico Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Batten Disease Drug Pipeline Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Batten Disease Drug Pipeline Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Batten Disease Drug Pipeline Market Share by Country (2016-2027)
Figure 53. Turkey Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Batten Disease Drug Pipeline Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Abeona Therapeutics Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 57. Amicus Therapeutics Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 58. Blue Turtle Bio Technologies Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 59. Circumvent Pharmaceuticals Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 60. Collaborations Pharmaceuticals Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 61. Exicure Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 62. Polaryx Therapeutics Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 63. RegenxBio Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 64. Retrotope Inc Revenue Growth Rate in Batten Disease Drug Pipeline Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のバッテン病治療市場規模・現状・予測（2021年-2027年）

Global Batten Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3891 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（作業療法、理学療法）、用途別市場規模（乳児NCL、後期乳児NCL、少年NCL、成人NCL）、主要地域別市場規模（北米、アメリカ、欧州、アジ...

世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Meniere Disease Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4490 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、メニエール病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（めまい、耳分泌物、その他）、用途別市場規模（病院・クリニック、専門センター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の耳鳴り治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Tinnitus Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4960 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、耳鳴り治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血管拡張薬、抗凝固薬、神経栄養薬）、用途別市場規模（病院・クリニック、専門センター）、主要地域別市場規模（北米、アメリカ、欧州、...

世界の黄斑変性症治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Macular Degeneration Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4452 2021年6月 126Pages
QYResearch社発行の本調査レポートでは、黄斑変性症治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療、小分子、幹細胞治療、遺伝子治療）、用途別市場規模（病院、研究所、商業、その他）、主要地域別市場規模（北米、アメリ...

世界の鎌状赤血球症治療薬に伴う血管閉塞危機市場規模・現状・予測（2021年-2027年）

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, Status and Forecast 2021-2027
QFJ1-6062 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、鎌状赤血球症治療薬に伴う血管閉塞危機の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SGD-2083、クリザンリズマブ、PF-04447943、NVX-508、その他）、用途別市場規模（クリニック、病...

世界の網膜疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Retinal Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4825 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、網膜疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、ア...

世界の関節疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Joint Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4400 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、関節疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、リハビリテーション、外科手術）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Pediatric Respiratory Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4675 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、小児呼吸器疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗炎症薬、気管支拡張薬、併用薬、コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（喘息、嚢胞性線維症、細気管支炎、肺...

世界の自己免疫疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Autoimmune Disease Drug Market Size, Status and Forecast 2021-2027
QFJ1-5604 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、自己免疫疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NSAID、抗炎症、インターフェロン、抗高血糖、その他）、用途別市場規模（関節リウマチ、1型糖尿病、多発性硬化症、乾癬、狼瘡、炎症性腸...

世界の脊索腫疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Chordoma Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4005 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、脊索腫疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（代謝拮抗剤、アントラサイクリン、VEGFR阻害剤、EGFR阻害剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（...

世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Meniere Disease Drug Pipeline Market The global Meniere Disease Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界のバッテン病治療市場規模・現状・予測（2021年-2027年） Batten disease is inherited disorder of the nervous system which begins in childhood.It is also called as neuronal ceroid lipofuscinoses (or NCLs). Batten Disease Treatment is the treatment of this type of disease. Market Analysis and Insights: Global Batten Disease Treatment Market The global Batte…
世界の耳鳴り治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tinnitus Drug Pipeline Market The global Tinnitus Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
世界の黄斑変性症治療薬パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Macular Degeneration Drug Pipeline Market The global Macular Degeneration Drug Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
世界の鎌状赤血球症治療薬に伴う血管閉塞危機市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-202…